At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 20 enrolled
Drug / intervention
Vitamin C +1 moredrug
Likely dose
Vitamin C 200mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Study of the Safety and Efficacy of Intravenous Vitamin C in Patients Undergoing Atrial Fibrillation Ablation
In Brief
A Phase 2 clinical trial evaluating Vitamin C and Placebo for Atrial Fibrillation Ablation. Completed, enrolled 20 participants across 1 site.
Detailed Summary
Single-center, double-blinded, randomized, controlled safety and feasibility pilot study of high dose IV ascorbic acid (200mg/kg) over 24 hours, divided into four doses and administered every six hours with a 30 minute IV infusion time per dose, compared to matched placebo infusion
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation Ablation
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedMay 2017
Enrollment StartSep 2017
Primary CompletionMar 2018
TodayJul 2026
First PostedMay 10, 2017
Enrollment StartSep 18, 2017
Primary CompletionMar 13, 2018
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 9.1 years ago
Interventions
Vitamin Cdrug
200mg/kg/day split into 4 doses infused every six hours over 30 minutes in 50ml D5W
Placeboother
50mL infused over 30 minutes